Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Biofactors (Oxford, England)
|
July 23, 1999
A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease
C W Shults, R H Haas, M F Beal
Journal of Neurochemistry
|
June 1, 1978
Myelin basic protein microheterogeneity in subfractions of rat brain myelin
C W Shults, J N Whitaker, J G Wood
Brain Research
|
July 12, 1991
Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior
L S Carman, F H Gage, C W Shults
Brain Research
|
November 14, 2000
Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine
C W Shults, J Ray, K Tsuboi, et al.
Experimental Neurology
|
June 1, 1992
Mesostriatal dopaminergic axons transiently express high levels of NILE during development
C W Shults, L Alberti, T A Kimber, et al.
Annals of Neurology
|
August 1, 1997
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects
C W Shults, R H Haas, D Passov, et al.
Neuroscience
|
January 1, 1990
Dopaminergic cells align along radial glia in the developing mesencephalon of the rat
C W Shults, R Hashimoto, R M Brady, et al.
AJNR. American Journal of Neuroradiology
|
January 1, 1986
Magnetic resonance imaging in Huntington disease
J T Simmons, B Pastakia, T N Chase, et al.
Brain Research
|
May 2, 1998
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
M F Beal, R T Matthews, A Tieleman, et al.
Neuroscience
|
May 1, 1984
Autoradiographic localization of substance P receptors in rat medulla: effect of vagotomy and nodose ganglionectomy
C J Helke, C W Shults, T N Chase, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Biofactors (Oxford, England)
|
July 23, 1999
A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease
C W Shults, R H Haas, M F Beal
Journal of Neurochemistry
|
June 1, 1978
Myelin basic protein microheterogeneity in subfractions of rat brain myelin
C W Shults, J N Whitaker, J G Wood
Brain Research
|
July 12, 1991
Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior
L S Carman, F H Gage, C W Shults
Brain Research
|
November 14, 2000
Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine
C W Shults, J Ray, K Tsuboi, et al.
Experimental Neurology
|
June 1, 1992
Mesostriatal dopaminergic axons transiently express high levels of NILE during development
C W Shults, L Alberti, T A Kimber, et al.
Annals of Neurology
|
August 1, 1997
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects
C W Shults, R H Haas, D Passov, et al.
Neuroscience
|
January 1, 1990
Dopaminergic cells align along radial glia in the developing mesencephalon of the rat
C W Shults, R Hashimoto, R M Brady, et al.
AJNR. American Journal of Neuroradiology
|
January 1, 1986
Magnetic resonance imaging in Huntington disease
J T Simmons, B Pastakia, T N Chase, et al.
Brain Research
|
May 2, 1998
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
M F Beal, R T Matthews, A Tieleman, et al.
Neuroscience
|
May 1, 1984
Autoradiographic localization of substance P receptors in rat medulla: effect of vagotomy and nodose ganglionectomy
C J Helke, C W Shults, T N Chase, et al.
Page
of 6